Document Detail


Mechanism Based Neurotoxicity of mGlu5 Positive Allosteric Modulators - development challenges for a promising novel antipsychotic target.
MedLine Citation:
PMID:  23291536     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Previous work has suggested that activation of mGlu5 receptor augments NMDA receptor function and thereby may constitute a rational approach addressing glutamate hypofunction in schizophrenia and a target for novel antipsychotic drug development. Here, we report the in vitro activity, in vivo efficacy and safety profile of 5PAM523 (4-Fluorophenyl){(2R,5S)-5-[5-(5-fluoropyridin-2-yl)-1,2,4-oxadiazol-3-yl]-2-methylpiperidin-1-yl}methanone), a structurally novel positive allosteric modulator selective of mGlu5. In cells expressing human mGlu5 receptor, 5PAM523 potentiated threshold responses to glutamate in fluorometric calcium assays, but does not have any intrinsic agonist activity. 5PAM523 acts as an allosteric modulator as suggested by the binding studies showing that 5PAM523 did not displace the binding of the orthosteric ligand quisqualic acid, but did partially compete with the negative allosteric modulator, MPyEP. In vivo, 5PAM523 reversed amphetamine-induced locomotor activity in rats. Therefore, both the in vitro and in vivo data demonstrate that 5PAM523 acts as a selective mGlu5 PAM and exhibits anti-psychotic like activity. To study the potential for adverse effects and particularly neurotoxicity, brain histopathological exams were performed in rats treated for 4 days with 5PAM523 or vehicle. The brain exam revealed moderate to severe neuronal necrosis in the rats treated with the doses of 30 and 50 mg/kg, particularly in the auditory cortex and hippocampus. To investigate whether this neurotoxicity is mechanism specific to 5PAM523, similar safety studies were carried out with three other structurally distinct selective mGlu5 PAMs. Results revealed a comparable pattern of neuronal cell death. Finally, 5PAM523 was tested in mGlu5 knock-out (KO) and wild type (WT) mice. mGlu5 WT mice treated with 5PAM523 for 4 days at 100 mg/kg presented significant neuronal death in the auditory cortex and hippocampus. Conversely, mGlu5 KO mice did not show any neuronal loss by histopathology, suggesting that enhancement of mGlu5 function is responsible for the toxicity of 5PAM523. This study reveals for the first time that augmentation of mGlu5 function with selective allosteric modulators results in neurotoxicity.
Authors:
S Parmentier-Batteur; Peter H Hutson; Karsten Menzel; Jason M Uslaner; Britta A Mattson; Julie A O'Brien; Brian C Magliaro; Thomas Forest; Craig A Stump; Robert M Tynebor; Neville J Anthony; Thomas J Tucker; Xu-Fang Zhang; Robert Gomez; Sarah L Huszar; Nathalie Lambeng; H Fauré; Emannuel Le Poul; Sonia Poli; Thomas W Rosahl; Jean-Philippe Rocher; Richard Hargreaves; Theresa M Williams
Related Documents :
24631746 - Determination of optimal acquisition time of [(18)f]fcway pet for imaging serotonin 1a ...
17079736 - Substrate selectivity of epidermal growth factor-receptor ligand sheddases and their re...
24140426 - The dopamine d1 receptor agonist skf 38393 improves temporal order memory performance i...
8089146 - Molecular cloning and expression of the acidic fibroblast growth factor receptors in a ...
12960776 - Actions of orexin-a in the myenteric plexus of the guinea-pig small intestine.
18447336 - Assessment of scaffold hopping efficiency by use of molecular interaction fingerprints.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-1-2
Journal Detail:
Title:  Neuropharmacology     Volume:  -     ISSN:  1873-7064     ISO Abbreviation:  Neuropharmacology     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-1-7     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0236217     Medline TA:  Neuropharmacology     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012. Published by Elsevier Ltd.
Affiliation:
Merck Research Laboratories, 770 Sumneytown Pike, West Point 19486, PA, USA. Electronic address: sophie_parmentier_batteur@merck.com.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Immunomodulatory and Cellular Anti-oxidant Activities of an Aqueous Extract of Limoniastrum guyonian...
Next Document:  HIV infection deregulates innate immunity to malaria despite combination antiretroviral therapy.